GSK2256098,
GSK2256098,
1224887-10-8,
GTPL7939,
GSK-2256098,
GSK 2256098,
GTPL7939;2-[[5-chloro-2-[(5-methyl-2-propan-2-ylpyrazol-3-yl)amino]pyridin-4-yl]amino]-N-methoxybenzamide,
BVAHPPKGOOJSPU-UHFFFAOYSA-N,
SCHEMBL691518,
UNII-R7O0O4110G,
EX-A671,
R7O0O4110G,
BCP18311,
MFCD30502650,
s8523,
AKOS030627136,
ZINC114407258,
CS-6083,
AC-29885,
AK676296,
HY-100498,
2-((5-Chloro-2-((1-isopropyl-3-methyl-1H-pyrazol-5-yl)amino)pyridin-4-yl)amino)-N-methoxybenzamide,
2-[(5-Chloro-2-{[3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino}-4-pyridiny)amino]-N-(methyloxy)benzamide,
2-[(5-Chloro-2-{[3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino}-4-pyridinyl)amino]-N-(methyloxy)benzamide,
2-[(5-chloro-2-{[3-methyl-1-(propan-2-yl)-1H-pyrazol-5-yl]amino}pyridin-4-yl)amino]-N-methoxybenzamide,
2-[[5-chloro-2-[[3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino]-4-pyridinyl]amino]-N-methoxybenzamide,
Benzamide, 2-[[5-chloro-2-[[3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino]-4-pyridinyl]amino]-N-methoxy-,
D0B9MR,
ACN-051244,
A15765,
Focal adhesion kinase inhibitor (oral, cancer), GlaxoSmithKline,